IGF-II R

IGF-II R

IGF-II R 詳細

Molecule Name
Insulin-like growth factor II receptor
分子の別称
Cation-independent mannose-6-phosphate receptor,CI Man-6-P receptor,CI-MPR,M6PR,300 kDa mannose 6-phosphate receptor (MPR 300),Insulin-like growth factor 2 receptor,Insulin-like growth factor II receptor (IGF-II receptor),M6P/IGF2 receptor (M6P/IGF2R),CD2
Drug Development Progress
治験薬の数0
市販薬剤の数1
研究&開発段階Approved
ターゲットの別称
Insulin-like growth factor 2 receptor,IGF-II receptor,CD222,Insulin Like Growth Factor 2 Receptor,M6P/IGF2R,M6P/IGF2 receptor,CI Man-6-P receptor,Insulin-like growth factor II receptor,IGF2R,300 KDa Mannose 6-Phosphate Receptor,MPR 300,MPRI,Cation-Independent Mannose-6-Phosphate Receptor,Cation-Independent Mannose-6 Phosphate Receptor,CD222 Antigen,CI-M6PR,MPR300,CI-MPR,CIMPR,M6P-R,MPR1,M6PR,Receptor, IGF Type 2
バックグランド
IGF2R, also known as the cation-independent mannose-6-phosphate receptor, is found ubiquitously in human tissues with a truncated soluble form of the receptor present in the circulation. Full-length, 300-kDa, IGF2R comprises a large N-terminal extracellular region of 15 homologous domains, a single membrane-spanning region and a small cytoplasmic tail. In addition to IGF-II binding, major IGF2R functions include sorting newly synthesized lysosomal enzymes and endocytosis of extracellular lysosomal enzymes. To perform these disparate functions, the extracellular region contains binding sites for IGF-II and phosphomannosyl residues

IGF-II R 製品リスト

Species
  • Human(2)
Tag
  • His Tag(2)
Host
  • CHO(1)
  • HEK293(1)
Conjugate
  • Unconjugated(2)
Grade
  • RUO(2)
Low Endotoxin
  • No(2)
MoleculeCat. No.Product Name種HostStructurePurityActivitySize&Price
IGF-II R
Human IGF-II R (43-1365) Protein, His Tag (MALS verified)
Human
HEK293
MALSSDS-PAGE

$360.00

100ug
IGF-II R
Human IGF-II R Protein, His Tag (MALS verified)
Human
CHO
MALSSDS-PAGE
ELISASPR

$360.00

100ug
You Have Viewed 1-2 Of 2 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Avalglucosidase alfaneoGAA; GZ-402666; Neo-rhGAA; NeoGAAApprovedGenzyme CorpNexviazyme, Nexviadyme, 耐而赞United StatesGlycogen Storage Disease Type IIGenzyme Corp2021-08-06
Glycogen Storage Disease Type II
詳細
Customer Reviews